BLOOMFIELD, Conn., Oct. 6, 2023 /PRNewswire/ -- To better align on quality care and reimburse providers for delivering improved health outcomes, Evernorth Health Services is launching an innovative measurement-based care program for its behavioral health network. This represents the first step in Evernorth's active collaboration with providers as the industry looks to create meaningful, standardized metrics for behavioral health care.
"Across the health care industry, we all understand the importance of measurement, and delivering quality behavioral health outcomes and care represents our next step in strengthening the interventions for our patients and deepening our relationships with providers," said Eva Borden, president, behavioral health, Evernorth. "Right now, there is a lack of consistent, repeatable measures – that are broadly agreed upon – resulting in more administrative work, and less trust, from our provider partners. This is the first step as we seek to actively collaborate with providers, as enhancing the provider experience is critical to the success of measurement-based care. We are creating a program that will deliver best-in-class clinical outcomes and multi-stakeholder affordability."
Measurement-based care, also referred to as value-based care, has long existed for physical health but has not seen the same adoption in behavioral health. In the journey toward behavioral measurement-based care, providers and payers have used a variety of measures, sharing them via spreadsheets or claims and document submissions to understand quality. The goal of this new program is to align on treatment measurements that can ultimately drive improvements in care, cost, and collaboration, as well as remove administrative burdens for providers.
"We are identifying the most important measurements at each point in the patient journey and creating standard ways to capture them," said Dr. Doug Nemecek, chief medical officer, behavioral health, Evernorth. "Our ongoing strategy involves building collaborations with key providers committed to quality outcomes and creating, with their partnership, interventions that will benefit patients, clients, and mental health professionals alike."
As part of the program's initial launch, Evernorth will work with over 44,000 providers, with plans to expand over time. The providers include behavioral health coaches, therapists, and prescribers who can help with a variety of mental health conditions, including anxiety, depression, sleep disorders, substance use disorders, and more. Evernorth has identified key metrics for the program to ensure that customers have quick access to high-quality care, including how long it takes a patient to get an appointment, avoidance of a higher level of care, and total cost-of-care savings. The program will add to these measures over time as Evernorth engages with providers to align on best metrics.
"By tracking this information, we can help move the needle in partnership with our providers as we all work together to improve care for the people we serve," Dr. Nemecek said. "We want our providers to be focused on patient care and not on paperwork, and we plan to incorporate measurement in ways that minimize the administrative burdens and maximize the benefits for providers and patients. By embedding shared metrics in the customer journey, both payers and providers will develop insights into access and outcomes that will benefit everyone."
About Evernorth Health Services
Evernorth Health Services creates pharmacy, care, and benefits solutions to improve health and increase vitality. We relentlessly innovate to make the prediction, prevention, and treatment of illness and disease more accessible to millions of people. Evernorth capabilities are powered by our businesses, including Express Scripts, Express Scripts Pharmacy, Accredo, eviCore, and MDLIVE, along with holistic Evernorth platforms and solutions that move people and organizations forward. All Evernorth solutions are serviced and provided by or through operating affiliates of Evernorth Health, a wholly owned subsidiary of The Cigna Group (NYSE: CI), or third-party partners. Learn more at evernorth.com.
Media Contact
Kelly Mathews
423.260.9267
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$333.01 |
Daily Change: | 4.56 1.39 |
Daily Volume: | 2,297,590 |
Market Cap: | US$92.630B |
October 31, 2024 September 12, 2024 September 12, 2024 August 01, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB